Cargando…
Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. Antibiotics 2021, 10, 1341
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030548/ https://www.ncbi.nlm.nih.gov/pubmed/35453287 http://dx.doi.org/10.3390/antibiotics11040464 |
| _version_ | 1784692168225456128 |
|---|---|
| author | Morroni, Gianluca Bressan, Raffaela Fioriti, Simona D’Achille, Gloria Mingoia, Marina Cirioni, Oscar Di Bella, Stefano Piazza, Aurora Comandatore, Francesco Mauri, Carola Migliavacca, Roberta Luzzaro, Francesco Principe, Luigi Lagatolla, Cristina |
| author_facet | Morroni, Gianluca Bressan, Raffaela Fioriti, Simona D’Achille, Gloria Mingoia, Marina Cirioni, Oscar Di Bella, Stefano Piazza, Aurora Comandatore, Francesco Mauri, Carola Migliavacca, Roberta Luzzaro, Francesco Principe, Luigi Lagatolla, Cristina |
| author_sort | Morroni, Gianluca |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9030548 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90305482022-04-23 Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. Antibiotics 2021, 10, 1341 Morroni, Gianluca Bressan, Raffaela Fioriti, Simona D’Achille, Gloria Mingoia, Marina Cirioni, Oscar Di Bella, Stefano Piazza, Aurora Comandatore, Francesco Mauri, Carola Migliavacca, Roberta Luzzaro, Francesco Principe, Luigi Lagatolla, Cristina Antibiotics (Basel) Correction MDPI 2022-03-30 /pmc/articles/PMC9030548/ /pubmed/35453287 http://dx.doi.org/10.3390/antibiotics11040464 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Correction Morroni, Gianluca Bressan, Raffaela Fioriti, Simona D’Achille, Gloria Mingoia, Marina Cirioni, Oscar Di Bella, Stefano Piazza, Aurora Comandatore, Francesco Mauri, Carola Migliavacca, Roberta Luzzaro, Francesco Principe, Luigi Lagatolla, Cristina Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. Antibiotics 2021, 10, 1341 |
| title | Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. Antibiotics 2021, 10, 1341 |
| title_full | Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. Antibiotics 2021, 10, 1341 |
| title_fullStr | Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. Antibiotics 2021, 10, 1341 |
| title_full_unstemmed | Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. Antibiotics 2021, 10, 1341 |
| title_short | Correction: Morroni et al. Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections. Antibiotics 2021, 10, 1341 |
| title_sort | correction: morroni et al. antimicrobial activity of aztreonam in combination with old and new β-lactamase inhibitors against mbl and esbl co-producing gram-negative clinical isolates: possible options for the treatment of complicated infections. antibiotics 2021, 10, 1341 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030548/ https://www.ncbi.nlm.nih.gov/pubmed/35453287 http://dx.doi.org/10.3390/antibiotics11040464 |
| work_keys_str_mv | AT morronigianluca correctionmorronietalantimicrobialactivityofaztreonamincombinationwitholdandnewblactamaseinhibitorsagainstmblandesblcoproducinggramnegativeclinicalisolatespossibleoptionsforthetreatmentofcomplicatedinfectionsantibiotics2021101341 AT bressanraffaela correctionmorronietalantimicrobialactivityofaztreonamincombinationwitholdandnewblactamaseinhibitorsagainstmblandesblcoproducinggramnegativeclinicalisolatespossibleoptionsforthetreatmentofcomplicatedinfectionsantibiotics2021101341 AT fioritisimona correctionmorronietalantimicrobialactivityofaztreonamincombinationwitholdandnewblactamaseinhibitorsagainstmblandesblcoproducinggramnegativeclinicalisolatespossibleoptionsforthetreatmentofcomplicatedinfectionsantibiotics2021101341 AT dachillegloria correctionmorronietalantimicrobialactivityofaztreonamincombinationwitholdandnewblactamaseinhibitorsagainstmblandesblcoproducinggramnegativeclinicalisolatespossibleoptionsforthetreatmentofcomplicatedinfectionsantibiotics2021101341 AT mingoiamarina correctionmorronietalantimicrobialactivityofaztreonamincombinationwitholdandnewblactamaseinhibitorsagainstmblandesblcoproducinggramnegativeclinicalisolatespossibleoptionsforthetreatmentofcomplicatedinfectionsantibiotics2021101341 AT cirionioscar correctionmorronietalantimicrobialactivityofaztreonamincombinationwitholdandnewblactamaseinhibitorsagainstmblandesblcoproducinggramnegativeclinicalisolatespossibleoptionsforthetreatmentofcomplicatedinfectionsantibiotics2021101341 AT dibellastefano correctionmorronietalantimicrobialactivityofaztreonamincombinationwitholdandnewblactamaseinhibitorsagainstmblandesblcoproducinggramnegativeclinicalisolatespossibleoptionsforthetreatmentofcomplicatedinfectionsantibiotics2021101341 AT piazzaaurora correctionmorronietalantimicrobialactivityofaztreonamincombinationwitholdandnewblactamaseinhibitorsagainstmblandesblcoproducinggramnegativeclinicalisolatespossibleoptionsforthetreatmentofcomplicatedinfectionsantibiotics2021101341 AT comandatorefrancesco correctionmorronietalantimicrobialactivityofaztreonamincombinationwitholdandnewblactamaseinhibitorsagainstmblandesblcoproducinggramnegativeclinicalisolatespossibleoptionsforthetreatmentofcomplicatedinfectionsantibiotics2021101341 AT mauricarola correctionmorronietalantimicrobialactivityofaztreonamincombinationwitholdandnewblactamaseinhibitorsagainstmblandesblcoproducinggramnegativeclinicalisolatespossibleoptionsforthetreatmentofcomplicatedinfectionsantibiotics2021101341 AT migliavaccaroberta correctionmorronietalantimicrobialactivityofaztreonamincombinationwitholdandnewblactamaseinhibitorsagainstmblandesblcoproducinggramnegativeclinicalisolatespossibleoptionsforthetreatmentofcomplicatedinfectionsantibiotics2021101341 AT luzzarofrancesco correctionmorronietalantimicrobialactivityofaztreonamincombinationwitholdandnewblactamaseinhibitorsagainstmblandesblcoproducinggramnegativeclinicalisolatespossibleoptionsforthetreatmentofcomplicatedinfectionsantibiotics2021101341 AT principeluigi correctionmorronietalantimicrobialactivityofaztreonamincombinationwitholdandnewblactamaseinhibitorsagainstmblandesblcoproducinggramnegativeclinicalisolatespossibleoptionsforthetreatmentofcomplicatedinfectionsantibiotics2021101341 AT lagatollacristina correctionmorronietalantimicrobialactivityofaztreonamincombinationwitholdandnewblactamaseinhibitorsagainstmblandesblcoproducinggramnegativeclinicalisolatespossibleoptionsforthetreatmentofcomplicatedinfectionsantibiotics2021101341 |